Editorial Comment

Affiliations

¹ Molecular Imaging Branch, National Cancer Institute, Bethesda, Maryland.
² Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland.

Comment

Peter Choyke et al. J Urol. 2021 Jul.

. 2021 Jul;206(1):60-61.

doi: 10.1097/JU.0000000000001698.01. Epub 2021 Apr 15.

¹ Molecular Imaging Branch, National Cancer Institute, Bethesda, Maryland.
² Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland.

No abstract available

Comment in

Reply by Authors.
Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, Saperstein L, Preston MA, Alva AS, Patnaik A, Durack JC, Stambler N, Lin T, Jensen J, Wong V, Siegel BA, Morris MJ. Pienta KJ, et al. J Urol. 2021 Jul;206(1):61. doi: 10.1097/JU.0000000000001698.02. Epub 2021 Apr 15. J Urol. 2021. PMID: 33853358 No abstract available.

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with ¹⁸F-DCFPyL in Prostate Cancer Patients (OSPREY).
Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, Saperstein L, Preston MA, Alva AS, Patnaik A, Durack JC, Stambler N, Lin T, Jensen J, Wong V, Siegel BA, Morris MJ. Pienta KJ, et al. J Urol. 2021 Jul;206(1):52-61. doi: 10.1097/JU.0000000000001698. Epub 2021 Feb 26. J Urol. 2021. PMID: 33634707 Free PMC article. Clinical Trial.